Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection

Patrick Dorr, Paul Stupple

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

2 Citations (Scopus)
Original languageEnglish
Title of host publicationAntiviral Drugs: From Basic Discovery through Clinical Trials
EditorsWieslaw M. Kazmierski
Place of PublicationHoboken NJ USA
PublisherJohn Wiley & Sons
Chapter9
Pages117-136
Number of pages20
ISBN (Print)9780470455630
DOIs
Publication statusPublished - 20 Jun 2011
Externally publishedYes

Keywords

  • HIV entry inhibitors, and maraviroc - PF-232798: CCR5 antagonists, HIV-1 treatment
  • Key stages, overarching SAR - maraviroc medicinal chemistry program, and PF-232798
  • Phase I-III clinical PK safety - and efficacy evaluation of maraviroc

Cite this